A year after FTC nixed Illumina buyout, SoftBank bets $900M on PacBio's new vision

A year after FTC nixed Illumina buyout, SoftBank bets $900M on PacBio's new vision

Source: 
Endpoints
snippet: 

A year after the FTC killed Pacific Biosciences’ $1.2 billion buyout by Illumina, California’s smaller genomic sequencing company has found a far different group to fork over a fortune.